Accuray Inc

ARAYNASDAQ · USD
2.44USD+2.32 (-4.32%)
612

Accuray Inc (ARAY) Covered Calls

Read more

Running ARAY covered calls helps you generate income from Accuray Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ARAY covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ARAY stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ARAY covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ARAY covered call is worth writing.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

No illustrative rows to display.

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank86.90% High
  • Market cap (M$)15
  • 52 weeks high-90.77%
  • 52 weeks low0.00%
  • Analyst recommendationHold
    3.00
  • Target price$0.35
    -85.66% below the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2027-02-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.15
  • EPS growth next 5 years—

As of Nov 5, 2026